FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094022 [Registered on: 01/09/2025] Trial Registered Prospectively
Last Modified On: 29/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Effectiveness of individualised homoeopathic Medicine in the management of insomnia in post menopausal women 
Scientific Title of Study   Role of individualised homoeopathic medicine in the management of insomnia in post menopausal women an open label single arm prospective clinical study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pushplata kumari 
Designation  Post graduate trainee  
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of organon of medicine opd no 14 and 31 GE block sector 3 salt lake kolkata west bengal 700106

Kolkata
WEST BENGAL
0
India 
Phone  6206360803  
Fax    
Email  pushplatakumari2722@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pushplata kumari 
Designation  Post graduate trainee  
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of organon of medicine opd no 14 and 31 GE block sector 3 salt lake kolkata west bengal 700106
National Institute of Homoeopathy Department of organon of medicine opd no 14 and 31 GE block sector 3 salt lake Kolkata west bengal 700106
Kolkata
WEST BENGAL
700106
India 
Phone  6206360803  
Fax    
Email  pushplatakumari2722@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ompriya Mishra 
Designation  Professor 
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of Obstetrics and Gynaecology opd 31 GE block sector 3 salt lake kolkata west bengal 700106
National Institute of Homoeopathy Department of Obstetrics and Gynaecology opd 31 GE block sector 3 salt lake kolkata west bengal 700106
Kolkata
WEST BENGAL
700106
India 
Phone  8240359414  
Fax    
Email  drompriyanih@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy GE block sector 3salt lake kolkata west bengal 700106 
 
Primary Sponsor  
Name  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy GE block sector 3 salt lake kolkata west bengal 700106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pushplata kumari  National Institute of Homoeopathy  National Institute of Homoeopathy Department of organon of medicine opd no 14 and 31 GE block sector 3 salt lake kolkata west bengal 700106
Kolkata
WEST BENGAL 
06206360803

pushplatakumari2722@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute of Homoeopathy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G470||Insomnia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised Homoeopathic medicine  All the patient’s symptoms and written information will be recorded in standard proforma that are used in NIH Kolkata. All the cases will be repertorised with Synthesis Repertory and final selection will be done after consultation with materia medica. Dose and frequency of the selected medicine will be as per the Homoeopathic principles. Indicated Individualized homoeopathic medicine will be prescribed. 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  1.Women aged 45-60 years experiencing natural menopause, from all religion and socioeconomic background.
2. Insomnia accompanied by menopausal symptoms like hot flashes, night sweat, mood disturbance or hormonal imbalance.
3. Patients suffering from chronic insomnia for more than three months.
4. patients with ability to read write / understand Hindi or English or Bengali.
5. Patients who are willing to participate in the study and giving informed written consent. 
 
ExclusionCriteria 
Details  1.Women with insomnia causes by underlying medical condition such as thyroid disorder, other serious chronic illness.
2.Patients on hormone replace therapy or other conventional medication superficially for insomnia.
3. Women with a history of severe psychiatric disorder such as major depression or bipolar disorder.
4.Patients not willing to take part in the study and not ready to give the written consent for the same.
5.Women undergoing induced menopause due to surgery. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The Womens Health Initiative Insomnia Rating Scale (WHIIRS).The scale requires individuals to rate the quality of their sleep and the frequency with which they experience certain sleep problems, providing a total score that may be useful for both research and clinical purposes.A Brief 5 item scale evaluating insomnia symptoms.Response options range from 0 to 4, resulting in a possible total score of 20, with a score greater than 9 indicating clinically significant Insomnia.  at the baseline and 6 month 
 
Secondary Outcome  
Outcome  TimePoints 
MENOPAUSAL RATING SCALE:
The Menopause Rating Scale (MRS) is a health-related quality of life scale (HRQoL) it was developed in response to the lack of standardized scales to measure the severity of aging-symptoms and their impact on the HRQoL in the early 1990s.
The MRS consists of a list of 11 items (symptoms or complaints). Each of the 11 symptoms contained in the scale can get 0 (no complaints) or up to 4 scoring points (severe symptoms) depending on the severity of the complaints perceived by the women completing the scale 
at the baseline and 6 month 
 
Target Sample Size   Total Sample Size="37"
Sample Size from India="37" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective, open label, single arm, clinical study will be conducted over 18 month at the National Institute of Homoeopathy, Kolkata, with each patient followed for six months. The study aim to evaluate the role of individualised Homoeopathic Medicine in the management of insomnia in post menopausal women. The primary objective is to determine the role of individualized homoeopathic medicine in the patients of insomnia in post- menopausal women by evaluating change in Women’s Health Initiative Insomnia rating scale after 6 months of treatment. The secondary objective is to evaluate change in Menopausal Rating Scale using individualized homeopathic medicine in insomnia in post-menopausal women associated after 6 months of treatment. A Women aged 45-60 years experiencing natural menopause, from all religion and socio- economic background. Insomnia accompanied by menopausal symptoms like hot flashes, night sweats, mood disturbance or hormonal imbalance. Patients suffering from chronic insomnia (difficulty initiating or maintaining sleep) for more than 3 months. Patients with ability to read /write /understand Hindi or English or Bengali. Patients who are willing to participate in the study and giving informed written consent will be included. Women with insomnia cause by underlying medical condition such as thyroid disorder, other serious chronic illness. Patients on hormone replacement therapy (HRT)or other conventional medication specifically for insomnia. Women with a history of severe psychiatric disorder such as major depression or bipolar disorder. Patients not willing to take part in the study and not ready to give the written consents for the same. Women undergoing induced menopause due to surgery will be excluded.Individualized homeopathic remedies will be selected based on repertorization (Synthesis Repertory) and Materia Medica, following Hahnemannian principles, with monthly follow-ups for six months to assess symptom changes. Treatment efficacy will be determined by comparing pre- and post-treatment of women’s health Initiative insomnia rating scale and menopausal rating scale. 
Close